Association of kappa light chain restriction with peripheral neuropathy among patients with non-IgM monoclonal gammopathy of undetermined significance.

被引：1
|
作者：
Dasanu, Constantin A.
Kaur, Jaspreet
Tuler, Shahaf
Farrell, Stephanie
Plaxe, Steven C.
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
[2] Eisenhower Med Ctr, Rancho Mirage, CA USA
[3] Univ Calif San Diego Hlth, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e20040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20040
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Uncommon Presentation of IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) and Anti-Myelin-Associated Glycoprotein (MAG)-Associated Demyelinating Peripheral Neuropathy as Respiratory Failure: A Case Report
    Tanariyakul, Manasawee
    Takaoka, Kensuke
    Takahashi, Toshiaki
    Estaris, Jonathan
    Sumida, Kenneth
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [42] Detection of free Kappa and Lambda light chain in serum and urine in patients with monoclonal gammopathy.
    Herzog, W
    Hofmann, W
    CLINICAL CHEMISTRY, 2004, 50 (06) : A182 - A182
  • [43] Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma
    Gran, Charlotte
    Liwing, Johan
    Wagner, Arnika Kathleen
    Verhoek, Andre
    Gezin, Ana
    Alici, Evren
    Nahi, Hareth
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (01) : 23 - 30
  • [44] The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening study
    Oskarsson, Jon Thorir
    Rognvaldsson, Saemundur
    Thorsteinsdottir, Sigrun
    Long, Thorir Einarsson
    Olafsson, Andri
    Eythorsson, Elias
    Jonsson, Asbjorn
    Vioarsson, Brynjar
    Onundarson, Pall T.
    Agnarsson, Bjarni A.
    Palmason, Robert
    Siguroardottir, Margret
    Thorsteinsdottir, Ingunn
    Olafsson, Isleifur
    Harding, Stephen J.
    Durie, Brian G. M.
    Love, Thorvardur Jon
    Kristinsson, Sigurdur Y.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [45] Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Light-Chain MGUS (LCMGUS) In a Metropolitan Area In Germany.
    Eisele, Lewin
    Duerig, Jan
    Huttmann, Andres
    Duehrsen, Ulrich
    Fuehrer, Anja
    Kieruzel, Sabrina
    Assert, Roland
    Bokhof, Beate
    Erbel, Raimund
    Mann, Klaus
    Joeckel, Karl-Heinz
    Moebus, Susanne
    BLOOD, 2010, 116 (21) : 1645 - 1646
  • [46] Adopting the new iStopMM-based criteria for light-chain monoclonal gammopathy of undetermined significance: an ongoing debate
    Shpitzer, Dor
    Cohen, Yael C.
    Shragai, Tamir
    Melamed, Guy
    Reiner-Benaim, Anat
    Avivi, Irit
    HAEMATOLOGICA, 2025, 110 (02) : 532 - 535
  • [47] Detection of MYD88 L265P in peripheral blood of patients with Waldenström’s Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance
    L Xu
    Z R Hunter
    G Yang
    Y Cao
    X Liu
    R Manning
    C Tripsas
    J Chen
    C J Patterson
    M Kluk
    S Kanan
    J Castillo
    N Lindeman
    S P Treon
    Leukemia, 2014, 28 : 1698 - 1704
  • [48] Serum Free Light Chain Assays in the Risk Stratification of Monoclonal Gammopathy of Undetermined Significance: Results from a Pharmacoeconomic Evaluation
    Pratt, Guy
    Cranmer, Holly
    Almond, Christine
    Harding, Stephen
    Powner, Dale John
    Hughes, Richard Geir
    Cook, Mark
    BLOOD, 2015, 126 (23)
  • [49] Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis
    Benedikt W. Pelzer
    Marina Arendt
    Susanne Moebus
    Lewin Eisele
    Karl-Heinz Jöckel
    Ulrich Dührsen
    Jan Dürig
    Annals of Hematology, 2018, 97 : 1463 - 1469
  • [50] Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis
    Pelzer, Benedikt W.
    Arendt, Marina
    Moebus, Susanne
    Eisele, Lewin
    Joeckel, Karl-Heinz
    Duehrsen, Ulrich
    Duerig, Jan
    ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1463 - 1469
12345